Cytosorbents vs Retractable Technologies
Cytosorbents and Retractable Technologies are similar in size: $37.1m and $38.3m of revenue in their latest fiscal years. Retractable Technologies grew faster (15.8% against 4.1%). Cytosorbents kept more of each dollar of sales as profit: a net margin of -22.1% against -32.8%. Retractable Technologies carries less debt relative to equity (1.2% against 311.7%).
| Latest fiscal year | CytosorbentsCTSO, 2025 | Retractable TechnologiesRVP, 2025 |
|---|---|---|
| Revenue | $37.1m | $38.3m |
| Revenue growth | 4.1% | 15.8% |
| Net income | −$8.2m | −$12.6m |
| Operating margin | -39.8% | -55.3% |
| Net margin | -22.1% | -32.8% |
| Return on equity | -96.4% | -15.6% |
| Free cash flow | −$12.5m | −$7.1m |
| Cash | $6.2m | $2.6m |
| Total debt | $18.4m | $895,645 |
| Debt to equity | 311.7% | 1.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 129 | 201 |
| Market value | $259m | $17.1m |
| Price vs our value range | — | — |
| Moat score | 28 (Weak) | 30 (Weak) |
| Insider trades, 12 months | 10 buys, 0 sales | 3 buys, 0 sales |